We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$912M
AUM Growth
+$112M
Cap. Flow
+$107M
Cap. Flow %
11.78%
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$18.6M
2
ARRY
Array Biopharma Inc
ARRY
+$16.5M
3
GILD icon
Gilead Sciences
GILD
+$16.3M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$13.4M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$12.5M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$20.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$14.2M
4
LOXO
Loxo Oncology, Inc
LOXO
+$12.8M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$9.64M

Sector Composition

Rank Sector Weight
1 Healthcare 91.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
26
DELISTED
TESARO, Inc.
TSRO
$12.9M 1.41%
225,260
+188,660
+515% +$12.1M
PRAH
27
DELISTED
PRA Health Sciences, Inc.
PRAH
$12.5M 1.37%
+150,560
New +$13.4M
COGT icon
28
Cogent Biosciences
COGT
$6.75B
$12M 1.32%
+270,386
New +$12M
PTCT icon
29
PTC Therapeutics
PTCT
$6.21B
$11.8M 1.3%
437,934
+65,300
+18% +$1.65M
ALDR
30
DELISTED
Alder Biopharmaceuticals
ALDR
$11M 1.2%
+863,600
New +$12.5M
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
$10.7M 1.17%
+96,000
New +$11.5M
NKTR icon
32
Nektar Therapeutics
NKTR
$2.3B
$10.5M 1.15%
6,594
-1,260
-16% -$1.62M
GKOS icon
33
Glaukos
GKOS
$9.31B
$10.1M 1.11%
+329,199
New +$9.97M
CI icon
34
Cigna
CI
$78.9B
$9.94M 1.09%
59,237
-8,378
-12% -$1.63M
IRTC icon
35
iRhythm Holdings
IRTC
$3.96B
$9.92M 1.09%
157,600
-37,200
-19% -$2.3M
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$9.69M 1.06%
+153,200
New +$9.86M
ESPR
37
DELISTED
Esperion Therapeutics
ESPR
$9.58M 1.05%
132,468
+109,135
+468% +$8.01M
NBIX icon
38
Neurocrine Biosciences
NBIX
$18.3B
$9.24M 1.01%
111,402
-30,900
-22% -$2.61M
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$9.03M 0.99%
186,994
-254,774
-58% -$14.2M
MOH icon
40
Molina Healthcare
MOH
$10.5B
$8.77M 0.96%
108,070
+55,810
+107% +$4.49M
XLRN
41
DELISTED
Acceleron Pharma
XLRN
$8.77M 0.96%
224,226
-488,130
-69% -$20.7M
NVRO
42
DELISTED
NEVRO CORP.
NVRO
$8.44M 0.93%
+97,400
New +$7.86M
ADMS
43
DELISTED
Adamas Pharmaceuticals
ADMS
$8.4M 0.92%
+351,320
New +$11.1M
PODD icon
44
Insulet
PODD
$11.7B
$8.19M 0.9%
94,509
– –
HRC
45
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$7.67M 0.84%
88,200
+18,750
+27% +$1.6M
VRAY
46
DELISTED
ViewRay, Inc.
VRAY
$7.33M 0.8%
1,139,863
+192,557
+20% +$1.6M
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$125B
$6.83M 0.75%
41,915
+5,200
+14% +$849K
IART icon
48
Integra LifeSciences
IART
$1.37B
$6.82M 0.75%
123,198
– –
INCY icon
49
Incyte
INCY
$25.3B
$6.6M 0.72%
79,245
+40,300
+103% +$3.63M
MASI
50
DELISTED
Masimo
MASI
$6.4M 0.7%
72,800
– –
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Sectoral Asset Management held 80 positions worth $912M, up 14% from $800M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sectoral Asset Management deployed $107M of net new capital in Q1 2018, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was Array Biopharma Inc: 1,031,650 shares worth $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 92% a quarter earlier.

On the sell side, the largest reduction was Acceleron Pharma, an estimated $20.7M trimmed.

  • Sectoral Asset Management's largest Q1 2018 buy was Array Biopharma Inc: 1,031,650 shares worth $16.8M.
  • Sectoral Asset Management added most to Exact Sciences in Q1 2018, an estimated $18.6M increase.
  • Sectoral Asset Management's biggest Q1 2018 reduction was Acceleron Pharma, cutting an estimated $20.7M.
  • Sectoral Asset Management fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $14.8M.
  • Sectoral Asset Management's ten largest holdings make up 36% of its $912M portfolio in Q1 2018.
  • Sectoral Asset Management opened 13 new positions and closed 12 in Q1 2018.
  • Sectoral Asset Management's portfolio value rose 14% quarter-over-quarter to $912M.

Based on Sectoral Asset Management's 13F filing for Q1 2018, filed 15 May 2018.